Separation of cathepsin A-like enzyme and the proteasome: Evidence that lactacystin/β-lactone is not a specific inhibitor of the proteasome

International Journal of Biochemistry and Cell Biology

Volumn 32, Issue 7, 2000, Pages 747-757

  Ostrowska, Halina ^a   Wójcik, Cezary ^a,c   Wilk, Sherwin ^c   Omura, Satoshi ^d   Kozlowski, Leszek ^a   Stoklosa, Tomasz ^b   Worowski, Krzysztof ^a   Radziwon, Piotr ^e  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Dept Immunol Biostructure C ^*  (Poland)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d KITASATO INSTITUTE   (Japan)

^e Regional Blood Transfusion Center   (Poland)

Author keywords

Cathepsin A; Human platelets; Lactacystin; Proteasome; PSI

Indexed keywords

CARBOXYPEPTIDASE C; CHYMOTRYPSIN; CONCANAVALIN A; LACTACYSTIN; PROTEASOME;

ARTICLE; CELL MEMBRANE PERMEABILITY; CHROMATOGRAPHY; HYDROLYSIS; MAMMAL; PH; PROTEIN DEGRADATION; THROMBOCYTE;

ACETYLCYSTEINE; ANIMALS; BLOOD PLATELETS; CARBOXYPEPTIDASE C; CELL LINE, TUMOR; CHROMATOGRAPHY, AFFINITY; CONCANAVALIN A; CYSTEINE PROTEINASE INHIBITORS; HEPARIN; HUMANS; MICE; PROTEASOME ENDOPEPTIDASE COMPLEX;

MAMMALIA;

EID: 17644444479     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(00)00021-2     Document Type: Article

References (35)

1. Mortensen U.H., Olesen K., Breddam K. Lysosomal carboxypeptidase A. Barrett A.J., Rawlings N.D., Waessner J.F. Handbook of Proteolytic Enzymes. 1998;393-397 Academic Press, San Diego, London, Boston, New York, Sydney, Tokyo, Toronto.
2. Skidgel R.A., Erdös E.G. Cellular carboxypeptidases. Immunol. Rev. 161:1998;12-141.
3. Coux O., Tanaka K., Goldberg A.L. Structure and function of the 20 S and 26 S proteasomes. Annu. Rev. Biochem. 65:1996;801-847.
4. Ostrowska H. Cathepsin A-like activity is possibly the main acidic carboxypeptidase in human platelets. Platelets. 8:1997;355-360.
5. Jackman H.L., Tan F., Tamei H., Beurling-Harbury C., Li X.Y., Skidgel R., Erdös E.G. A peptidase in human platelets that deamidates tachykinins. J. Biol. Chem. 265:1990;11265-11272.
6. Yukawa M., Sakon M., Kambayashi I., Shiba E., Kawaski T., Ariyoshi H., Mori T. Proteasome and its novel endogenous activator in human platelets. Biochem. Biophys. Res. Commun. 178:1991;256-262.
7. Galjart N.I., Morreau H., Willemsen R., Gillemans N., Bonten E.J., d'Azzo A. Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function. J. Biol. Chem. 266:1991;14754-14762.
8. Pshezhetsky A.V., Potier M. Direct affinity purification and supramolecular organization of human lysosomal cathepsin A. Arch. Biochem. Biophys. 313:1994;64-70.
9. Ostrowska H., Wójcik C., Omura S., Worowski K. Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme. Biochem. Biophys. Res. Commun. 234:1997;729-732.
10. Fenteany G., Standaert R.F., Lane W.S., Choi S., Corey E.J., Schreiber S.L. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science. 268:1995;726-731.
11. Dick L.R., Cruikshank A.A., Grenier L., Melandri F.D., Nunes S.L., Stein R.L. Mechanistics studies on the inactivation of the proteasome by lactacystin. J. Biol. Chem. 271:1996;7273-7276.
12. Craiu A., Gaczynska M., Akopian T., Gramm C.F., Fenteany G., Goldberg A.L., Rock K.L. Lactacystin and clasto-lactacystin β-lactone modify multiple proteasome β-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J. Biol. Chem. 272:1997;13437-13445.
13. Fenteany G., Schreiber S.L. Lactacystin, proteasome functions and cell fate. J. Biol. Chem. 273:1998;8545-8548.
14. Orlowski M., Michaud C. Pituitary multicatalytic proteinase complex. Specificity of components and aspects of proteolytic activity. Biochemistry. 28:1998;9270-9278.
15. Mason R.W. Characterization of the active site of human muticatalytic proteinase. Biochem. J. 265:1990;479-484.
16. Figueiredo-Pereira M., Chen W., Yuan H., Wilk S. A novel chymotrypsin-like component of the multicatalytic proteinase complex optimally active at acidic pH. Archiv. Biochem. Biophys. 317:1995;69-78.
17. Ostrowska H. Cathepsin A activity in thrombin-activated human platelets. Thromb. Res. 86:1997;393-404.
18. Wilk S., Figueiredo-Pereira M.E. Synthetic inhibitors of the multicatalytic proteinase complex (proteasome). Enzyme Protein. 47:1993;306-313.
19. Omura S., Matsuzaki K., Fujimoto T., Kosuge K., Furuya T., Fujita S., Nakagawa S. Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells. J. Antibiotics. 44:1991;117-118.
20. Miller J.J., Changaris D.G., Levy R.S. Purification, subunit structure and inhibitor profile of cathepsin A. J. Chromatogr. 627:1992;153-162.
21. Moore S. Amino acid analysis: aqueous dimethyl sulfoxide as solvent for ninhydrin reaction. J. Biol. Chem. 243:1968;6281-6283.
22. Bradford M.M. A rapid and sensitive method for the quatitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
23. Kaltoft M.B., Koch C., Uerkvitz W., Hendil K.B. Monoclonal antibodies to the human multicatalytic proteinase (proteasome). Hybridoma. 11:1992;507-517.
24. Hanna W.L., Turbov J.M., Jackman H.L., Tan F., Froelich C.J. Dominant chymotrypsin-like esterase activity in human lymphocyte granules is mediated by the serine carboxypeptidase called cathepsin A-like protective protein. J. Immunol. 153:1994;4663-4672.
25. Weitman D., Etlinger J.D. A monoclonal antibody that distinguishes latent and active forms of the proteasome (multicatalytic proteinase complex). J. Biol. Chem. 267:1992;6977-6982.
26. Lee D.H., Goldberg A.L. Proteasome inhibitors: valuable new tools for cell biologists. Trends in Cell Biol. 8:1998;397-403.
27. Wójcik C. Inhibition of the proteasome as a therapeutic approach. Drug Disc. Today. 4:1999;188-192.
28. Meng L., Mohan R., Kwok B.H.B., Elofsson M., Sin N., Crews C.M. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo anti-inflammatory activity. Proc. Natl Acad. Sci. USA. 96:1999;10403-10408.
29. Dick L.R., Cruikshank A.A., Destree A.T., Grenier L., McCormack T.A., Melandri F.D., Nunes S.L., Palombella V.I., Parent L.A., Plamondon L., Stein R.L. Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells. J. Biol. Chem. 272:1997;182-188.
30. Hinek A. Biological roles of the non-integrin elastin/laminin receptor. Biol. Chem. 377:1996;471-480.
31. Miller J.J., Changaris D.G., Levy R.S. Conversion of angiotensin I to angiotensin II by cathepsin A isoenzymes of porcine kidney. Biochem. Biophys. Res. Commun. 154:1988;1122-1129.
32. Polasek J. Lysosomal concept of platelet secretion-revisited. Eur. J. Haematol. 43:1983;3-24.
33. Schmitt M., Janicke F., Graeff F. Tumor-associated proteases. Fibrinolysis. 6:(Suppl. 4):1992;3-26.
34. Kageshita T., Yoshii A., Kimura T. Biochemical and immunohistochemical analysis of cathepsins B, H, L and D in human melanocytic tumours. Arch. Dermatol. Res. 287:1995;266-272.
35. Geier E., Pfeifer G., Wilm M., Lucchiari-Hartz M., Baumeister W., Eichmann K., Niedermann G. A giant protease with potential to substitute for some functions of the proteasome. Science. 283:1999;978-981.